Conference abstract
Conference abstractPublished 1 Oct 2012
Establishing the necessary data to model the future resource requirements and predicted healthcare targets for cell therapy as part of routine clinical practice
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
S tem cell science has advanced to where patient benefits are starting to emerge. However, if cell therapies are to realize their full potential and become routine clinical practice for large numbers of patients, additional science coupled to commercial translation will be essential. The cell therapy industry (CTI) is presently a small but potentially rapidly growing new global healthcare sector. Success is totally dependent on resolving a number of factors unique to cells as therapies including: mechanisms of action, manufacturing, regulation and clinical trials. To understand how to solve these challenges, it is essential to robustly forecast the size and resource demands of the sector over the next two decades. Due to the highly regulated nature of medicines, one reliable method is to analyze the therapies that are currently undergoing clinical trials � the future pipeline. A search was performed on the website clinicaltrials.gov using the embedded search-engine and key terms relating to �cell therapy�. 17,362 files were extracted (27/06/2010) and individually screened for relevance using the British Standard Institute (BSI) definition of �cell therapy�. The resulting 2,765 trials were then categorized and core information collated including: trial phase, cell source (autologous/allogeneic), current activity of the trial and responsible national regulatory agency. Key results: [1] Near equal number of autologous and allogeneic trials, [2] Majority of trials are late-stage, [3] Significantly larger number of transient cell therapies as opposed to permanent cell replacement. This poster highlights all the key findings and discusses the implications for discovery scientists, clinicians, businesses and governments.
Subjects
BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 1 Dec 2016
PPPM (Predictive, Preventive and Personalized Medicine) as an Upgraded Model of National and International Healthcare Services to Secure a Future of Clinical Research and Practice: How to Promote the Higher Medical Education
Conference abstract · 30 Jun 2016
Predictive, preventive and personalized medicine (PPPM) as an upgraded model of national and international healthcare services to secure a future of clinical research and practice
Conference abstract
Predictive, preventive and personalized medicine (PPPM) as an upgraded model of national and international healthcare services to secure a future of clinical research and practice: How to promote the higher medical educa
Conference abstract · 29 May 2023
Improving a CHD Prediction Model, Reducing Necessary Predictive Factors, and Statistical Analysis of the Data
More from this journal
The newest in Journal of Cell Science & Therapy.
Perspective · 2 Feb 2026
Exploring Senescence and Its Influence on Tissue Function and Therapeutic Research
Commentary · 2 Feb 2026
Metabolism Regulation and Its Influence on Therapeutic Development in Human Disease
Commentary · 2 Dec 2025
Cellular Membranes and Transport Proteins as Regulators of Homeostasis and Metabolic Coordination
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cell Science & Therapy
- SubjectBiology
- BylineArticles whose byline prints “Emily J. Culme-Seymour”

